Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Waldmann

Showing results (431-440 of 442) with videos related to

Pageof 45
Sort By:
Blood|November 14, 1997
Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I alpha1 domainL Genestier, R Paillot, N Bonnefoy-Berard, et al.
Blood|September 25, 1999
Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcomeA Green, E Clarke, L Hunt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 16, 2008
CD8+ T-Cell depletion and rapamycin synergize with combined coreceptor/stimulation blockade to induce robust limb allograft tolerance in miceZ Li, F S Benghiat, L Marie Charbonnier, et al.
British Journal of Haematology|December 11, 2002
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortalitySuparno Chakrabarti, Irit Avivi, Stephen Mackinnon, et al.
Bone Marrow Transplantation|July 5, 2001
Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcomeR M Barge, R E Brouwer, M F Beersma, et al.
Blood|November 1, 1995
Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipientA Spencer, R M Szydlo, P A Brookes, et al.
Diabetologia|March 13, 2010
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell massB Keymeulen, M Walter, C Mathieu, et al.
Bone Marrow Transplantation|August 5, 2000
CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cellsG Hale, P Jacobs, L Wood, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 11, 2005
Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticityJ Hoffmann, Y Feng, F vom Hagen, et al.
Cytotherapy|August 13, 2002
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantationP D Kottaridis, D W Milligan, R Chopra, et al.
Pageof 45

Showing results (431-440 of 442) with videos related to

Sort By:
Pageof 45
Blood|November 14, 1997
Fas-independent apoptosis of activated T cells induced by antibodies to the HLA class I alpha1 domainL Genestier, R Paillot, N Bonnefoy-Berard, et al.
Blood|September 25, 1999
Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcomeA Green, E Clarke, L Hunt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 16, 2008
CD8+ T-Cell depletion and rapamycin synergize with combined coreceptor/stimulation blockade to induce robust limb allograft tolerance in miceZ Li, F S Benghiat, L Marie Charbonnier, et al.
British Journal of Haematology|December 11, 2002
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortalitySuparno Chakrabarti, Irit Avivi, Stephen Mackinnon, et al.
Bone Marrow Transplantation|July 5, 2001
Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: effect of stem cell source on short- and long-term outcomeR M Barge, R E Brouwer, M F Beersma, et al.
Blood|November 1, 1995
Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipientA Spencer, R M Szydlo, P A Brookes, et al.
Diabetologia|March 13, 2010
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell massB Keymeulen, M Walter, C Mathieu, et al.
Bone Marrow Transplantation|August 5, 2000
CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cellsG Hale, P Jacobs, L Wood, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 11, 2005
Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticityJ Hoffmann, Y Feng, F vom Hagen, et al.
Cytotherapy|August 13, 2002
In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantationP D Kottaridis, D W Milligan, R Chopra, et al.
Pageof 45